YC Biotech and Xinkang Community Health Care Group have officially joined forces to introduce EG BioMed’s DNA methylation cancer marker testing to a wider audience. The partnership was celebrated with a signing banquet at the Royal Host Restaurant in Luzhou, where both organizations reaffirmed their commitment to advancing early cancer detection through cutting-edge medical technology. […]
Taichung– Date July, 2023 YC Biotech Co., Ltd. recently partnered with Taichung Yien Clinic to host a successful training program for healthcare professionals, aimed at promoting DNA methylation cancer biomarker testing developed by EG BioMed Co., Ltd. This testing method offers a simple, rapid, and accurate approach, providing patients with a more comfortable diagnostic experience.
YC Biotech and Xinxi Community Health Care Group have officially joined forces to expand access to EG BioMed’s DNA methylation cancer marker testing. The collaboration was celebrated with a signing banquet at Lemon Grass Restaurant in Xinzhuang, where both organizations reaffirmed their shared commitment to enhancing early cancer detection through innovative medical technology. This cutting-edge
YC Biotech and Xinxi Community Health Care Group Co-host Signing Banquet Read More »
YC Biotech has officially signed the “DNA Methylation Cancer Marker Testing Agreement” with multiple clinics within the New Banqiao Health Care Group, marking a significant step forward in the clinical adoption of breast cancer methylation testing. The agreement was formalized during a signing banquet, underscoring a shared commitment to advancing early cancer detection through cutting-edge
YC Biotech and New Banqiao Health Care Group Co-host Signing Banquet Read More »
YC Biotech and XinLe Community Health Care Group have officially joined forces to advance breast cancer screening, celebrating their partnership with a signing banquet at the renowned “Daddy’s Kitchen” restaurant in Yonghe District. This collaboration will bring cutting-edge breast cancer methylation testing technology to multiple clinics within the XinLe network, offering patients a more precise
YC Biotech and XinLe Community Health Care Group Co-host Signing Banquet Read More »
YC Biotech has officially signed a strategic cooperation agreement with Worlder Hands Technology, marking a significant step toward advancing the digital transformation of the biotechnology industry. This collaboration brings together YC Biotech’s expertise in new drug development, CRO services, and commercialization planning with Worlder Hands Technology’s proficiency in statistical analysis, metrology, and digital management solutions.
YC Biotech and Happy Taipei Community Health Care Group hosted a signing banquet on the 19th in Taipei City, marking the beginning of a collaboration aimed at introducing EG BioMed’s innovative DNA methylation breast cancer detection technology to the group’s network of clinics. This partnership is set to enhance early breast cancer detection with a
YC Biotech and Happy Taipei Community Health Care Group Jointly Hold Signing Banquet Read More »
YC Biotech, the exclusive distributor of EG BioMed’s DNA methylation breast cancer detection technology, recently introduced this groundbreaking diagnostic tool to medical professionals at Xinmei Community Health Care Group in Tucheng. This advanced technology provides a more precise and innovative approach to early breast cancer detection, enhancing diagnostic accuracy and post-treatment monitoring. Developed by EG
YC Biotech and Xinmei Community Healthcare Group Jointly Hold Signing Meeting Read More »
Taipei City – May 12, 2023 MATRIXLabs Medical and YC Biotech have announced the signing of a memorandum of cooperation, marking a significant step toward enhancing the production efficiency and market adoption of laparoscopic suture knotting devices. MATRIXLabs Medical, a company dedicated to cutting-edge medical device development, has introduced an innovative laparoscopic suture knotting device
Taipei City – April 12, 2023 YC Biotech, a global leader in advanced biotechnology research and development, has officially partnered with Getraising Biotechnology, a premier cosmetics and skincare OEM manufacturer under the Neogence Group. The two companies have formalized their collaboration by signing a memorandum of cooperation, marking the beginning of a long-term strategic alliance.
